CEBP CTRC-AACR San Antonio Breast Cancer Symposium Translational Cancer Medicine 2008: Cancer Clinical Trials and Personalized Medicine
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Cell Growth & Differentiation

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wärnberg, F.
Right arrow Articles by Holmberg, L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wärnberg, F.
Right arrow Articles by Holmberg, L.
Cancer Epidemiology Biomarkers & Prevention Vol. 10, 495-499, May 2001
© 2001 American Association for Cancer Research

Risk Factors for Subsequent Invasive Breast Cancer and Breast Cancer Death after Ductal Carcinoma in Situ

A Population-based Case-Control Study in Sweden1

Fredrik Wärnberg2, Jonas Bergh, Matthew Zack and Lars Holmberg

Department of Surgery, University Hospital, S-751 85 Uppsala, Sweden [F. W.]; Department of Oncology, Karolinska Hospital, 17176 Stockholm, Sweden [J. B.]; National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia 30333 [M. Z.]; and Regional Oncological Center, 75185 Uppsala-Örebro, Sweden [L. H.]

In a case-control study derived from a cohort of 4661 women with a primary carcinoma in situ of the breast, we investigated age at diagnosis, mode of detection, tumor characteristics, and primary therapy, as prognostic factors for developing invasive breast cancer or dying from breast cancer. From all of the women with a primary carcinoma in situ reported to the Swedish Cancer Registry from 1960 through 1992, we selected as cases all of the women with a ductal carcinoma in situ who later died of breast cancer (n = 39) or who developed a subsequent invasive cancer in either breast (n = 118). From this cohort, we also selected controls matched to the cases by year of diagnosis and health care region. We conducted univariate and multivariate analyses to study the association between risk of invasive cancer or death and the different risk factors. Large size, diameter >=25 mm [odds ratio (OR), 3.5; 95% confidence interval (CI), 1.1–11.4] and multifocality (OR, 3.9; 95% CI, 1.2–12.7) increased the risk of breast cancer death in univariate analysis. Postoperative radiotherapy (OR, 0.1; 95% CI, 0.0–1.0) and mastectomy (OR, 0.1–95% CI, 0.0–0.5) lowered the risk of an ipsilateral invasive cancer in multivariate analysis. The risk pattern by treatment category differed between those who had an ipsilateral invasive cancer and those who either had a contralateral cancer or died from breast cancer. The driving forces behind local and generalized disease may differ. Because confounding by indication may influence the effects of different treatments, the results should be interpreted with caution.




This article has been cited by other articles:


Home page
Ann. Surg. Oncol.Home page
P. Meijnen, H. S. A. Oldenburg, J. L. Peterse, H. Bartelink, and E. J. Th. Rutgers
Clinical Outcome after Selective Treatment of Patients Diagnosed with Ductal Carcinoma In Situ of the Breast
Ann. Surg. Oncol., January 1, 2008; 15(1): 235 - 243.
[Abstract] [Full Text] [PDF]


Home page
Toxicol PatholHome page
R. D. Cardiff, A. Rosner, M. A. Hogarth, J. J. Galvez, A. D. Borowsky, and J. P. Gregg
Validation: The New Challenge for Pathology
Toxicol Pathol, January 1, 2004; 32(1_suppl): 31 - 39.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Cell Growth & Differentiation
Copyright © 2001 by the American Association for Cancer Research.